Delivery Order SPE2DB24D9238-SPE2DB25FDQLT

Award Date 1/31/25
Potential Completion Date 2/24/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $30,110.40, is a firm fixed-price delivery order for the supply of MITOSOL 0.2 MG KITS, a pharmaceutical product. The contract award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,263.24 firm fixed-price delivery order is for the supply of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a period of performance through January 15, 2025. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,684.40, is for the delivery of MITOSOL 0.2MG KITS 3S and has a period of performance through June 28, 2024. This order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a ceiling value of $1,315.80 and a period of performance through March 21, 2025. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,631.62 firm fixed-price delivery order is for the supply of MITOSOL 0.2 MG KITS, with a period of performance through November 1, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $6,579.00, is for the delivery of MITOSOL 0.2 MG KITS with a period of performance through March 29, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, contract number SPE2DB24FYN58, with a ceiling value of up to $4,999,999 that DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,947.40 contract is for the delivery of MITOSOL 0.2 MG KITS, a specialized pharmaceutical product, with a performance period through November 29, 2024. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,263.24 firm fixed-price delivery order is for the supply of MITOSOL 0.2 MG KITS, with a period of performance through October 11, 2024. The award is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $3,947.40 and is for the delivery of MITOSOL 0.2 MG KITS through April 3, 2024. The contract is part of DMS Pharmaceutical Group's existing indefinite delivery contract with the DLA under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,631.62 firm fixed-price delivery order is for the supply of MITOSOL 0.2 MG KITS, a pharmaceutical product, with an ultimate completion date of October 18, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB25FDQLT
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $1,315.80 with a firm fixed-price pricing type and a period of performance through February 24, 2025.

The contract covers the delivery of MITOSOL 0.7 MG KITS, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, positioning DMS Pharmaceutical Group as a key supplier in the federal pharmaceutical supply chain. The contract does not have a set-aside designation.

Generated 5/2/25, 10:20 AM